blank LMU Munich Faculty for Chemistry and Pharmacy
print
 

Dr. Müge Molbay

Dr. Müge Molbay (Postdoc)

Since January 2024 Postdoc, LMU Munich
2023- 2024 Staff Scientist, Institute of Tissue Engineering and Regenerative Medicine, Helmholtz Zentrum München
2019: Visiting PhD Researcher, Material Research Institute, Pennsylvania State University, PA, USA
2018-2023: PhD student in Medical School, Ludwig-Maximilians-Universität München, Germany
2014-2018 MSc in Department of Histology and Embryology, Medical Faculty, Akdeniz University, Antalya, Turkey
2009 - 2014 Bsc in Molecular Biology and Genetics, Izmir Institute of Technology, Izmir, Turkey

Publications:

S. Rademacker, S. Carneiro, M. Molbay, F. Catapano, I. Forné, A. Imhof, R. Wibel, C. Heidecke, P. Hölig, O. Merkel, The impact of lipid compositions on siRNA and mRNA lipid nanoparticle performance for pulmonary delivery, European Journal of Pharmaceutical Sciences, 2025, 107182, ISSN 0928-0987

F. Sieber-Schäfer, M. Jiang, A. Kromer, A. Nguyen, M. Molbay, S. Pinto Carneiro, D. Jürgens, G. Burgstaller, B. Popper, B. Winkeljann, O. M. Merkel, Machine Learning-Enabled Polymer Discovery for Enhanced Pulmonary siRNA Delivery. Adv. Funct. Mater. 2025, e02805.

S. Chen, A. Nguyen, J. T Müller, M. Molbay, A. Mehta, S. Sheshachala, K. Baskaya, N. Adams, S. P. Carneiro, O. M. Merkel*: Engineered-affibody conjugates contribute to the specific targeting and cellular retention of polyplexes in Erbb3 overexpressed lung cancer cells Eur J Pharm Sci 2025

Patents: